Literature DB >> 3945043

Tumor immunogenicity--the prime determinant of the nutritional influence on the host-tumor relationship.

J W McCarrick, C B Ikeda, M M Ziegler.   

Abstract

The influence which malnutrition plays on the host-tumor relationship is controversial because of the disparity of human and rodent tumors, a critical difference being the minimal immunogenicity of human tumors and the variable antigenicity of rodent tumors. The hypothesis we tested is that the influence of malnutrition on tumor growth is a result of the immunogenicity of the host's tumor. C-1300 neuroblastoma (NB) is an immunogenic tumor by in vivo and in vitro assessment while the histologically identical TBJ-NB clone is non-immunizing. Isogeneic A/J mice were malnourished with 2.5% protein chow and were inoculated with C-1300-NB or TBJ-NB; either serial tumor volumes were assessed by three-dimensional measurement or animals were serially killed and tumor weight/carcass weight ratios (TW/CW) were calculated. Non-immunogenic TBJ-NB grew more rapidly than C-1300-NB in both control and malnourished groups, but there was no difference in either tumor size or TW/CW ratios between the two TBJ-NB nutritional groups. Contrasting with these data were immunogenic C-1300-NB in that the tumor grew significantly better in malnourished mice (tumor volume p less than 0.05 day 12 and 14; TW/CW p less than 0.026 by day 21). Prior whole-body irradiation abrogated this difference. These data demonstrate that for tumors differing only in antigenicity the influence of malnutrition is on that tumor which induces an immunologic antitumor response.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3945043     DOI: 10.1177/014860718601000121

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  2 in total

1.  Total parenteral nutrition prevents further nutritional deterioration in patients with cancer cachexia.

Authors:  F Bozzetti; M Ammatuna; S Migliavacca; M G Bonalumi; G Facchetti; A Pupa; G Terno
Journal:  Ann Surg       Date:  1987-02       Impact factor: 12.969

2.  Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma.

Authors:  Yunhu Yu; Yu Zeng; Xiangping Xia; Jian-Guo Zhou; Fang Cao
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.